Global Peripheral Artery Revascularisation Market Research Report 2024

Publication ID:

PB505252411

Publication Date:

May 10, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Peripheral arteries are blood vessels that carry blood from the heart to the arms, legs and other organs apart from the brain and heart. Peripheral artery disease is the most common form of peripheral vessels disease. Peripheral artery revascularisation is required when blood is not supplied efficiently to peripheral organs.听
The global Peripheral Artery Revascularisation market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Peripheral Artery Revascularisation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peripheral Artery Revascularisation.
Report Scope
The Peripheral Artery Revascularisation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peripheral Artery Revascularisation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peripheral Artery Revascularisation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Medtronic
AngioDynamics
C. R. Bard
Terumo Corporation
Boston Scientific Corporation
Cook Medical
Cardinal Health
Philips Healthcare
Segment by Type
Lower Extremity Revascularisation
Renal Arterial Revascularisation
Mesenteric Arterial Revascularisation
Abdominal Aortic Revascularisation
Others
Segment by Application
Hospitals
Specialty Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peripheral Artery Revascularisation companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peripheral Artery Revascularisation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Lower Extremity Revascularisation
1.2.3 Renal Arterial Revascularisation
1.2.4 Mesenteric Arterial Revascularisation
1.2.5 Abdominal Aortic Revascularisation
1.2.6 Others
1.3 Market by Application
1.3.1 Global Peripheral Artery Revascularisation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peripheral Artery Revascularisation Market Perspective (2019-2030)
2.2 Peripheral Artery Revascularisation Growth Trends by Region
2.2.1 Global Peripheral Artery Revascularisation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Peripheral Artery Revascularisation Historic Market Size by Region (2019-2024)
2.2.3 Peripheral Artery Revascularisation Forecasted Market Size by Region (2025-2030)
2.3 Peripheral Artery Revascularisation Market Dynamics
2.3.1 Peripheral Artery Revascularisation Industry Trends
2.3.2 Peripheral Artery Revascularisation Market Drivers
2.3.3 Peripheral Artery Revascularisation Market Challenges
2.3.4 Peripheral Artery Revascularisation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peripheral Artery Revascularisation Players by Revenue
3.1.1 Global Top Peripheral Artery Revascularisation Players by Revenue (2019-2024)
3.1.2 Global Peripheral Artery Revascularisation Revenue Market Share by Players (2019-2024)
3.2 Global Peripheral Artery Revascularisation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peripheral Artery Revascularisation Revenue
3.4 Global Peripheral Artery Revascularisation Market Concentration Ratio
3.4.1 Global Peripheral Artery Revascularisation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peripheral Artery Revascularisation Revenue in 2023
3.5 Peripheral Artery Revascularisation Key Players Head office and Area Served
3.6 Key Players Peripheral Artery Revascularisation Product Solution and Service
3.7 Date of Enter into Peripheral Artery Revascularisation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Artery Revascularisation Breakdown Data by Type
4.1 Global Peripheral Artery Revascularisation Historic Market Size by Type (2019-2024)
4.2 Global Peripheral Artery Revascularisation Forecasted Market Size by Type (2025-2030)
5 Peripheral Artery Revascularisation Breakdown Data by Application
5.1 Global Peripheral Artery Revascularisation Historic Market Size by Application (2019-2024)
5.2 Global Peripheral Artery Revascularisation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Peripheral Artery Revascularisation Market Size (2019-2030)
6.2 North America Peripheral Artery Revascularisation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Peripheral Artery Revascularisation Market Size by Country (2019-2024)
6.4 North America Peripheral Artery Revascularisation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peripheral Artery Revascularisation Market Size (2019-2030)
7.2 Europe Peripheral Artery Revascularisation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Peripheral Artery Revascularisation Market Size by Country (2019-2024)
7.4 Europe Peripheral Artery Revascularisation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peripheral Artery Revascularisation Market Size (2019-2030)
8.2 Asia-Pacific Peripheral Artery Revascularisation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Peripheral Artery Revascularisation Market Size by Region (2019-2024)
8.4 Asia-Pacific Peripheral Artery Revascularisation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peripheral Artery Revascularisation Market Size (2019-2030)
9.2 Latin America Peripheral Artery Revascularisation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Peripheral Artery Revascularisation Market Size by Country (2019-2024)
9.4 Latin America Peripheral Artery Revascularisation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peripheral Artery Revascularisation Market Size (2019-2030)
10.2 Middle East & Africa Peripheral Artery Revascularisation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Peripheral Artery Revascularisation Market Size by Country (2019-2024)
10.4 Middle East & Africa Peripheral Artery Revascularisation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Peripheral Artery Revascularisation Introduction
11.1.4 Abbott Laboratories Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Detail
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Peripheral Artery Revascularisation Introduction
11.2.4 Medtronic Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.2.5 Medtronic Recent Development
11.3 AngioDynamics
11.3.1 AngioDynamics Company Detail
11.3.2 AngioDynamics Business Overview
11.3.3 AngioDynamics Peripheral Artery Revascularisation Introduction
11.3.4 AngioDynamics Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.3.5 AngioDynamics Recent Development
11.4 C. R. Bard
11.4.1 C. R. Bard Company Detail
11.4.2 C. R. Bard Business Overview
11.4.3 C. R. Bard Peripheral Artery Revascularisation Introduction
11.4.4 C. R. Bard Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.4.5 C. R. Bard Recent Development
11.5 Terumo Corporation
11.5.1 Terumo Corporation Company Detail
11.5.2 Terumo Corporation Business Overview
11.5.3 Terumo Corporation Peripheral Artery Revascularisation Introduction
11.5.4 Terumo Corporation Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.5.5 Terumo Corporation Recent Development
11.6 Boston Scientific Corporation
11.6.1 Boston Scientific Corporation Company Detail
11.6.2 Boston Scientific Corporation Business Overview
11.6.3 Boston Scientific Corporation Peripheral Artery Revascularisation Introduction
11.6.4 Boston Scientific Corporation Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.6.5 Boston Scientific Corporation Recent Development
11.7 Cook Medical
11.7.1 Cook Medical Company Detail
11.7.2 Cook Medical Business Overview
11.7.3 Cook Medical Peripheral Artery Revascularisation Introduction
11.7.4 Cook Medical Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.7.5 Cook Medical Recent Development
11.8 Cardinal Health
11.8.1 Cardinal Health Company Detail
11.8.2 Cardinal Health Business Overview
11.8.3 Cardinal Health Peripheral Artery Revascularisation Introduction
11.8.4 Cardinal Health Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.8.5 Cardinal Health Recent Development
11.9 Philips Healthcare
11.9.1 Philips Healthcare Company Detail
11.9.2 Philips Healthcare Business Overview
11.9.3 Philips Healthcare Peripheral Artery Revascularisation Introduction
11.9.4 Philips Healthcare Revenue in Peripheral Artery Revascularisation Business (2019-2024)
11.9.5 Philips Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Abbott Laboratories
Medtronic
AngioDynamics
C. R. Bard
Terumo Corporation
Boston Scientific Corporation
Cook Medical
Cardinal Health
Philips Healthcare

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂